Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2021-11-01 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Bioneer regarding the exercise of conversion rights (convertible bonds into shares). It details the correction of a previously filed report concerning the listing date of the converted shares. Since this involves the issuance of new shares resulting from the conversion of debt (convertible bonds), it falls under the category of capital changes or share issues.
2021-11-01 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Bioneer, detailing quarterly financial performance (3Q 2021) including revenue, operating profit, and net income. It explicitly states these are provisional figures (잠정치) provided for investor convenience before final audit. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results. Q3 2021
2021-10-29 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Bioneer regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2021-10-15 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from Bioneer regarding the acquisition of convertible bonds before maturity (Call Option exercise). It details the bond series, acquisition amount, acquisition date, and the reason for the transaction. This falls under capital structure changes and financing activities, specifically related to debt instruments. Given the specific nature of the filing (bond repurchase/cancellation), it fits best under the 'CAP' (Capital/Financing Update) category.
2021-09-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, specifically regarding the major shareholder and CEO (Park Han-oh) of Bioneer Corporation, including changes in collateralized shares. This falls under the category of major shareholding notifications.
2021-09-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience (institutional investors), purpose, and the agenda (company introduction, investment points, etc.). Since this is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-09-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.